Literature DB >> 8949258

Use of structural imaging to study the progression of Alzheimer's disease.

A D Smith1, K A Jobst.   

Abstract

Computed tomographic scans in the temporal lobe orientation are a valuable way of studying the medial temporal lobe. In patients with histopathologically-confirmed Alzheimer's disease the size of the medial temporal lobe is almost half that in age-matched controls and the rate of atrophy shown by yearly scans (15% per year) is 10-fold greater. Such a rapid rate of atrophy probably follows a catastrophic event in the brain indicating that Alzheimer's disease is distinct from accelerated normal ageing. The degree of medial temporal lobe atrophy is related to the density of neurofibrillary tangles in the hippocampus; it is a useful guide to diagnosis and has potential as a screening tool in populations. It is proposed that measurement of the rate of atrophy in asymptomatic individuals may be a predictor of Alzheimer's disease and could be used to monitor the effectiveness of therapies designed to retard the rate of neurodegeneration.

Entities:  

Mesh:

Year:  1996        PMID: 8949258     DOI: 10.1093/oxfordjournals.bmb.a011568

Source DB:  PubMed          Journal:  Br Med Bull        ISSN: 0007-1420            Impact factor:   4.291


  13 in total

1.  Combining short interval MRI in Alzheimer's disease: Implications for therapeutic trials.

Authors:  J M Schott; C Frost; J L Whitwell; D G Macmanus; R G Boyes; M N Rossor; N C Fox
Journal:  J Neurol       Date:  2006-09-22       Impact factor: 4.849

2.  A review of neuroimaging biomarkers of Alzheimer's disease.

Authors:  Tinu Varghese; R Sheelakumari; Jija S James; Ps Mathuranath
Journal:  Neurol Asia       Date:  2013       Impact factor: 0.183

3.  Comparisons between global and focal brain atrophy rates in normal aging and Alzheimer disease: Boundary Shift Integral versus tracing of the entorhinal cortex and hippocampus.

Authors:  Frank Ezekiel; Linda Chao; John Kornak; An-Tao Du; Valerie Cardenas; Diana Truran; William Jagust; Helena Chui; Bruce Miller; Kristine Yaffe; Norbert Schuff; Michael Weiner
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Oct-Dec       Impact factor: 2.703

4.  Sex and age differences in atrophic rates: an ADNI study with n=1368 MRI scans.

Authors:  Xue Hua; Derrek P Hibar; Suh Lee; Arthur W Toga; Clifford R Jack; Michael W Weiner; Paul M Thompson
Journal:  Neurobiol Aging       Date:  2010-08       Impact factor: 4.673

5.  Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia.

Authors:  C R Jack; D W Dickson; J E Parisi; Y C Xu; R H Cha; P C O'Brien; S D Edland; G E Smith; B F Boeve; E G Tangalos; E Kokmen; R C Petersen
Journal:  Neurology       Date:  2002-03-12       Impact factor: 9.910

6.  Relations between hypometabolism in the posterior association neocortex and hippocampal atrophy in Alzheimer's disease: a PET/MRI correlative study.

Authors:  K Meguro; C LeMestric; B Landeau; B Desgranges; F Eustache; J C Baron
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-09       Impact factor: 10.154

7.  Temporal horn index and volume of medial temporal lobe atrophy using a new semiautomated method for rapid and precise assessment.

Authors:  F L Giesel; H K Hahn; P A Thomann; E Widjaja; E Wignall; H von Tengg-Kobligk; J Pantel; P D Griffiths; H O Peitgen; J Schroder; M Essig
Journal:  AJNR Am J Neuroradiol       Date:  2006-08       Impact factor: 3.825

8.  Patients with vascular dementia due to microvascular pathology have significant hippocampal neuronal loss.

Authors:  J J Kril; S Patel; A J Harding; G M Halliday
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-06       Impact factor: 10.154

Review 9.  Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia.

Authors:  Howard Chertkow; Fadi Massoud; Ziad Nasreddine; Sylvie Belleville; Yves Joanette; Christian Bocti; Valérie Drolet; John Kirk; Morris Freedman; Howard Bergman
Journal:  CMAJ       Date:  2008-05-06       Impact factor: 8.262

10.  Alzheimer's disease therapeutic research: the path forward.

Authors:  Paul S Aisen
Journal:  Alzheimers Res Ther       Date:  2009-07-09       Impact factor: 6.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.